Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genfit

Clinical trials sponsored by Genfit, explained in plain language.

Genfit GNFT EURONEXT PARIS

A biopharmaceutical company developing treatments for liver diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Completed 1 Terminated 2

New drug duo targets hard-to-treat bile duct cancer

Disease control Recruiting now

This study tests a combination of two drugs, GNS561 and trametinib, in people with advanced bile duct cancer that has a specific genetic change (KRAS mutation) and has not responded to standard first-line therapy. The trial has two phases: first to find the safest dose, then to s…

Phase: PHASE1, PHASE2 • Sponsor: Genfit • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC